DELIVERING ON A PROMISE: THE ICA FOUNDATION

摘要

THE PROBLEM The levonorgesterel intrauterine system (LNG IUS) provides up to five years of safe, effective, and continuous contraception. Developed by the Population Council and Finlandbased Bayer OY, the LNG IUS is distributed by Bayer HealthCare Pharmaceuticals in the private market under the trade name Mirena? in more than 120 countries. In low-resource settings, the LNG IUS is often inaccessible due to financial barriers and supply chain challenges.